Description: Headquartered in suburban Atlanta, Georgia, Artivion, Inc. (Artivion) is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult clinical challenges in treating patients with aortic diseases. This multinational company's four major groups of products include: aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion markets and sells products in more than 100 countries worldwide.
Home Page: artivion.com
AORT Technical Analysis
1655 Roberts Boulevard N.W.
Kennesaw,
GA
30144
United States
Phone:
770 419 3355
Officers
| Name | Title |
|---|---|
| Mr. James Patrick Mackin | Chairman, Pres & CEO |
| Mr. David Ashley Lee CPA, CPA | Exec. VP, COO & CFO |
| Ms. Jean F. Holloway Esq. | Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. |
| Mr. John E. Davis | Sr. VP of Global Sales & Marketing |
| Dr. Marshall S. Stanton M.D. | Sr. VP of Clinical Research & Chief Medical Officer |
| Ms. Amy D. Horton CPA, CPA | VP & Chief Accounting Officer |
| Mr. Matthew A. Getz | VP of HR |
| Mr. Dennis B. Maier | Sr. VP of Operations |
| Joshua Wells | Sr. Director of Bus. Devel. |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| Forward PE: | 357.1429 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.0504 |
| Price-to-Sales TTM: | 1.6348 |
| IPO Date: | 1993-02-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 1300 |